Acciones Eastgate Biotech Corp. Other OTC
Acciones
ETBI
US2772531008
Farmacéuticos
Ventas 2015 | 0,13 0,12 | Ventas 2016 | - | Capitalización | 9,82 M 9,12 M |
---|---|---|---|---|---|
Resultado Neto 2015 | -4 M -3,72 M | Resultado Neto 2016 | -2 M -1,86 M | VE / Ventas 2015 | 52.069.161 x |
Deuda neta 2015 | 1,35 M 1,25 M | Deuda neta 2016 | 1,72 M 1,6 M | VE / Ventas 2016 | - |
P/E ratio 2015 |
-0,85
x | P/E ratio 2016 |
-3,28
x | Empleados | - |
Rendimiento 2015 * |
-
| Rendimiento 2016 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15/01/15 |
William Abajian
PSD | President | 66 | 01/06/16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12/04/17 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22/05/12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+21,85 % | 546 mil M | |
-4,77 % | 359 mil M | |
+16,97 % | 323 mil M | |
+5,69 % | 290 mil M | |
+13,68 % | 234 mil M | |
+3,65 % | 198 mil M | |
-11,12 % | 194 mil M | |
+8,08 % | 167 mil M | |
-3,40 % | 157 mil M |